RxDoctor Payments DataLook up a doctor →

William Irvin, MD

Hematology & Oncology · Midlothian, VANPI 1700903242

Payments from drug & device makers

$4,276,601in general payments, 2019–2025

Across 436 payments — averaging $9808.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.5M
  • Pfizer$986K
  • AstraZeneca$503K
  • Eli Lilly$220K
  • Biontech SE$214K
  • Regeneron$205K
  • plus $661K from 13 others

General payments by program year

20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,276,601 in reported general payments places this provider in the 95th percentile of 293 hematology & oncology providers in Virginia.

See all hematology & oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$107,402
Medicare patients
311
Services billed
1,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →